Anika Therapeutics, Inc. (ANIK)
USD 14.13
(-3.81%)
USD 14.13
(-3.81%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -82.66 Million USD | -456.34% |
| 2022 | -14.85 Million USD | -459.43% |
| 2021 | 4.13 Million USD | 117.24% |
| 2020 | -23.98 Million USD | -188.19% |
| 2019 | 27.19 Million USD | 45.25% |
| 2018 | 18.72 Million USD | -41.16% |
| 2017 | 31.81 Million USD | -2.25% |
| 2016 | 32.54 Million USD | 5.82% |
| 2015 | 30.75 Million USD | -19.73% |
| 2014 | 38.31 Million USD | 86.25% |
| 2013 | 20.57 Million USD | 74.99% |
| 2012 | 11.75 Million USD | 38.87% |
| 2011 | 8.46 Million USD | 96.17% |
| 2010 | 4.31 Million USD | 17.04% |
| 2009 | 3.68 Million USD | 1.61% |
| 2008 | 3.62 Million USD | -39.87% |
| 2007 | 6.03 Million USD | 31.08% |
| 2006 | 4.6 Million USD | -21.87% |
| 2005 | 5.89 Million USD | -47.34% |
| 2004 | 11.19 Million USD | 1253.08% |
| 2003 | 827 Thousand USD | 127.2% |
| 2002 | -3.03 Million USD | 55.01% |
| 2001 | -6.75 Million USD | -3993.68% |
| 2000 | 173.55 Thousand USD | 106.94% |
| 1999 | -2.5 Million USD | -158.14% |
| 1998 | 4.3 Million USD | 30.3% |
| 1997 | 3.3 Million USD | 222.22% |
| 1996 | -2.7 Million USD | -35.0% |
| 1995 | -2 Million USD | -42.86% |
| 1994 | -1.4 Million USD | 12.5% |
| 1993 | -1.6 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -4.51 Million USD | 92.83% |
| 2024 Q2 | -88 Thousand USD | 98.05% |
| 2024 Q3 | -29.91 Million USD | -33897.73% |
| 2023 FY | -82.66 Million USD | -456.34% |
| 2023 Q1 | -10.35 Million USD | -110.88% |
| 2023 Q2 | -2.74 Million USD | 73.52% |
| 2023 Q4 | -63 Million USD | -858.03% |
| 2023 Q3 | -6.57 Million USD | -139.91% |
| 2022 Q1 | -2.93 Million USD | 49.37% |
| 2022 Q2 | -2.84 Million USD | 3.07% |
| 2022 FY | -14.85 Million USD | -459.43% |
| 2022 Q3 | -4.17 Million USD | -46.85% |
| 2022 Q4 | -4.9 Million USD | -17.56% |
| 2021 Q2 | 6.53 Million USD | 130.13% |
| 2021 FY | 4.13 Million USD | 117.24% |
| 2021 Q4 | -5.79 Million USD | -1138.17% |
| 2021 Q1 | 2.83 Million USD | 118.13% |
| 2021 Q3 | 558 Thousand USD | -91.46% |
| 2020 FY | -23.98 Million USD | -188.19% |
| 2020 Q1 | 3.46 Million USD | -14.56% |
| 2020 Q2 | -7.7 Million USD | -322.71% |
| 2020 Q4 | -15.65 Million USD | -144.22% |
| 2020 Q3 | -6.41 Million USD | 16.83% |
| 2019 FY | 27.19 Million USD | 45.25% |
| 2019 Q1 | 4.5 Million USD | -41.6% |
| 2019 Q2 | 9.43 Million USD | 109.34% |
| 2019 Q3 | 9.2 Million USD | -2.49% |
| 2019 Q4 | 4.05 Million USD | -55.97% |
| 2018 FY | 18.72 Million USD | -41.16% |
| 2018 Q4 | 7.71 Million USD | 1.55% |
| 2018 Q1 | -6.68 Million USD | -182.88% |
| 2018 Q3 | 7.59 Million USD | -24.7% |
| 2018 Q2 | 10.09 Million USD | 250.93% |
| 2017 Q4 | 8.06 Million USD | 17.13% |
| 2017 Q2 | 11.36 Million USD | 106.97% |
| 2017 Q1 | 5.49 Million USD | -32.06% |
| 2017 Q3 | 6.88 Million USD | -39.42% |
| 2017 FY | 31.81 Million USD | -2.25% |
| 2016 FY | 32.54 Million USD | 5.82% |
| 2016 Q4 | 8.08 Million USD | -9.68% |
| 2016 Q3 | 8.95 Million USD | 3.91% |
| 2016 Q2 | 8.61 Million USD | 24.95% |
| 2016 Q1 | 6.89 Million USD | -37.56% |
| 2015 Q4 | 11.04 Million USD | 31.77% |
| 2015 Q2 | 7.81 Million USD | 122.43% |
| 2015 Q1 | 3.51 Million USD | -55.02% |
| 2015 FY | 30.75 Million USD | -19.73% |
| 2015 Q3 | 8.37 Million USD | 7.17% |
| 2014 Q4 | 7.81 Million USD | 26.66% |
| 2014 Q3 | 6.17 Million USD | -33.66% |
| 2014 FY | 38.31 Million USD | 86.25% |
| 2014 Q1 | 15.03 Million USD | 125.87% |
| 2014 Q2 | 9.3 Million USD | -38.11% |
| 2013 FY | 20.57 Million USD | 74.99% |
| 2013 Q4 | 6.65 Million USD | 34.23% |
| 2013 Q3 | 4.95 Million USD | -15.91% |
| 2013 Q2 | 5.89 Million USD | 92.14% |
| 2013 Q1 | 3.06 Million USD | -31.26% |
| 2012 Q1 | 1.91 Million USD | -33.68% |
| 2012 Q4 | 4.46 Million USD | 171.28% |
| 2012 FY | 11.75 Million USD | 38.87% |
| 2012 Q3 | 1.64 Million USD | -55.97% |
| 2012 Q2 | 3.73 Million USD | 95.43% |
| 2011 Q1 | 324.41 Thousand USD | -75.98% |
| 2011 Q4 | 2.88 Million USD | -3.14% |
| 2011 FY | 8.46 Million USD | 96.17% |
| 2011 Q2 | 2.28 Million USD | 603.62% |
| 2011 Q3 | 2.97 Million USD | 30.4% |
| 2010 FY | 4.31 Million USD | 17.04% |
| 2010 Q3 | 1.18 Million USD | 11.02% |
| 2010 Q2 | 1.06 Million USD | 49.35% |
| 2010 Q4 | 1.35 Million USD | 14.05% |
| 2010 Q1 | 714.28 Thousand USD | 2.46% |
| 2009 Q2 | 955.77 Thousand USD | 82.85% |
| 2009 Q1 | 522.72 Thousand USD | -52.24% |
| 2009 FY | 3.68 Million USD | 1.61% |
| 2009 Q3 | 1.51 Million USD | 58.19% |
| 2009 Q4 | 697.14 Thousand USD | -53.89% |
| 2008 Q1 | 617.55 Thousand USD | -63.1% |
| 2008 Q4 | 1.09 Million USD | -0.88% |
| 2008 Q3 | 1.1 Million USD | 35.83% |
| 2008 FY | 3.62 Million USD | -39.87% |
| 2008 Q2 | 812.92 Thousand USD | 31.64% |
| 2007 Q2 | 1.36 Million USD | 13.66% |
| 2007 FY | 6.03 Million USD | 31.08% |
| 2007 Q4 | 1.67 Million USD | -6.84% |
| 2007 Q3 | 1.79 Million USD | 31.61% |
| 2007 Q1 | 1.2 Million USD | 14.71% |
| 2006 Q2 | 1.35 Million USD | 53.51% |
| 2006 Q4 | 1.04 Million USD | -20.98% |
| 2006 Q3 | 1.32 Million USD | -2.03% |
| 2006 Q1 | 880.74 Thousand USD | 7.15% |
| 2006 FY | 4.6 Million USD | -21.87% |
| 2005 FY | 5.89 Million USD | -47.34% |
| 2005 Q4 | 822 Thousand USD | -67.52% |
| 2005 Q3 | 2.53 Million USD | 89.3% |
| 2005 Q2 | 1.33 Million USD | 11.23% |
| 2005 Q1 | 1.2 Million USD | -31.51% |
| 2004 Q2 | 765 Thousand USD | -90.17% |
| 2004 FY | 11.19 Million USD | 1253.08% |
| 2004 Q4 | 1.75 Million USD | 98.53% |
| 2004 Q3 | 884 Thousand USD | 15.56% |
| 2004 Q1 | 7.78 Million USD | 872.03% |
| 2003 Q1 | -313 Thousand USD | -147.49% |
| 2003 FY | 827 Thousand USD | 127.2% |
| 2003 Q4 | 801 Thousand USD | 90.71% |
| 2003 Q3 | 420 Thousand USD | 618.52% |
| 2003 Q2 | -81 Thousand USD | 74.12% |
| 2002 Q3 | -737.64 Thousand USD | 36.26% |
| 2002 FY | -3.03 Million USD | 55.01% |
| 2002 Q1 | -1.8 Million USD | -295.0% |
| 2002 Q2 | -1.15 Million USD | 35.86% |
| 2002 Q4 | 659.08 Thousand USD | 189.35% |
| 2001 FY | -6.75 Million USD | -3993.68% |
| 2001 Q4 | -456.75 Thousand USD | 65.71% |
| 2001 Q3 | -1.33 Million USD | 49.74% |
| 2001 Q1 | -2.31 Million USD | -199.12% |
| 2001 Q2 | -2.65 Million USD | -14.32% |
| 2000 Q4 | 2.33 Million USD | 269.14% |
| 2000 FY | 173.55 Thousand USD | 106.94% |
| 2000 Q3 | -1.38 Million USD | -532.9% |
| 2000 Q2 | -218.48 Thousand USD | 61.27% |
| 2000 Q1 | -564.08 Thousand USD | 82.91% |
| 1999 Q3 | - USD | -100.0% |
| 1999 Q2 | 400 Thousand USD | 33.33% |
| 1999 FY | -2.5 Million USD | -158.14% |
| 1999 Q1 | 300 Thousand USD | -57.14% |
| 1999 Q4 | -3.3 Million USD | 0.0% |
| 1998 Q2 | 2.2 Million USD | 266.67% |
| 1998 Q3 | 700 Thousand USD | -68.18% |
| 1998 Q4 | 700 Thousand USD | 0.0% |
| 1998 Q1 | 600 Thousand USD | -80.0% |
| 1998 FY | 4.3 Million USD | 30.3% |
| 1997 Q1 | 200 Thousand USD | 122.22% |
| 1997 Q3 | -300 Thousand USD | -200.0% |
| 1997 FY | 3.3 Million USD | 222.22% |
| 1997 Q2 | 300 Thousand USD | 50.0% |
| 1997 Q4 | 3 Million USD | 1100.0% |
| 1996 Q4 | -900 Thousand USD | 0.0% |
| 1996 Q3 | -900 Thousand USD | -50.0% |
| 1996 Q2 | -600 Thousand USD | 33.33% |
| 1996 Q1 | -900 Thousand USD | -80.0% |
| 1996 FY | -2.7 Million USD | -35.0% |
| 1995 FY | -2 Million USD | -42.86% |
| 1995 Q2 | -500 Thousand USD | -150.0% |
| 1995 Q4 | -500 Thousand USD | 44.44% |
| 1995 Q3 | -900 Thousand USD | -80.0% |
| 1995 Q1 | -200 Thousand USD | 50.0% |
| 1994 Q2 | -500 Thousand USD | -150.0% |
| 1994 Q4 | -400 Thousand USD | 20.0% |
| 1994 Q3 | -500 Thousand USD | 0.0% |
| 1994 FY | -1.4 Million USD | 12.5% |
| 1994 Q1 | -200 Thousand USD | -100.0% |
| 1993 FY | -1.6 Million USD | 0.0% |
| 1993 Q3 | -500 Thousand USD | -25.0% |
| 1993 Q2 | -400 Thousand USD | 0.0% |
| 1993 Q4 | -100 Thousand USD | 80.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | -61.61 Million USD | -34.16% |
| BrainsWay Ltd. | -4.19 Million USD | -1869.669% |
| Cerus Corporation | -37.48 Million USD | -120.51% |
| Envoy Medical, Inc. | -29.9 Million USD | -176.404% |
| electroCore, Inc. | -18.83 Million USD | -338.924% |
| Helius Medical Technologies, Inc. | -8.85 Million USD | -834.09% |
| IceCure Medical Ltd | -14.65 Million USD | -464.203% |
| Inogen, Inc. | -102.44 Million USD | 19.309% |
| OrthoPediatrics Corp. | -20.97 Million USD | -294.14% |
| Lucid Diagnostics Inc. | -52.66 Million USD | -56.965% |
| Monogram Orthopaedics, Inc. | -13.74 Million USD | -501.424% |
| MaxCyte, Inc. | -37.92 Million USD | -117.986% |
| NeuroOne Medical Technologies Corporation | -11.85 Million USD | -597.054% |
| Nexalin Technology, Inc. | -4.64 Million USD | -1678.279% |
| Orthofix Medical Inc. | -151.39 Million USD | 45.396% |
| PAVmed Inc | -64.17 Million USD | -28.815% |
| Rapid Micro Biosystems, Inc. | -52.46 Million USD | -57.56% |
| RxSight, Inc. | -48.6 Million USD | -70.069% |
| Sight Sciences, Inc. | -55.54 Million USD | -48.824% |
| SI-BONE, Inc. | -43.33 Million USD | -90.758% |
| TELA Bio, Inc. | -46.66 Million USD | -77.154% |
| Treace Medical Concepts, Inc. | -49.52 Million USD | -66.913% |
| Vivos Therapeutics, Inc. | -13.58 Million USD | -508.606% |
| Acutus Medical, Inc. | -81.66 Million USD | -1.229% |
| Talis Biomedical Corporation | -62 Million USD | -33.319% |
| Spectral AI, Inc. | -20.85 Million USD | -296.408% |
| Nano-X Imaging Ltd. | -60.77 Million USD | -36.019% |
| CVRx, Inc. | -41.19 Million USD | -100.653% |
| DIH Holding US, Inc. Warrants | 640.19 Thousand USD | 13012.764% |
| PetVivo Holdings, Inc. | -10.95 Million USD | -654.585% |
| Bioventus Inc. | -156.23 Million USD | 47.086% |
| Venus Concept Inc. | -37.25 Million USD | -121.925% |
| TriSalus Life Sciences, Inc. | -59.03 Million USD | -40.023% |
| LivaNova PLC | 17.54 Million USD | 571.144% |
| 908 Devices Inc. | -36.39 Million USD | -127.113% |
| Alphatec Holdings, Inc. | -186.63 Million USD | 55.707% |
| Nemaura Medical Inc. | -14.14 Million USD | -484.478% |
| NeuroPace, Inc. | -32.95 Million USD | -150.841% |
| LENSAR, Inc. | -14.38 Million USD | -474.755% |
| Apyx Medical Corporation | -18.71 Million USD | -341.762% |
| Cutera, Inc. | -162.83 Million USD | 49.232% |
| STRATA Skin Sciences, Inc. | -10.83 Million USD | -663.315% |
| BioSig Technologies, Inc. | -29.04 Million USD | -184.656% |
| ClearPoint Neuro, Inc. | -22.08 Million USD | -274.245% |
| Integra LifeSciences Holdings Corporation | 67.74 Million USD | 222.034% |
| Axonics, Inc. | -6.08 Million USD | -1257.868% |
| Outset Medical, Inc. | -172.79 Million USD | 52.159% |
| IRIDEX Corporation | -9.57 Million USD | -763.814% |
| PROCEPT BioRobotics Corporation | -105.89 Million USD | 21.936% |
| IRadimed Corporation | 17.19 Million USD | 580.824% |
| Tivic Health Systems, Inc. | -8.24 Million USD | -902.754% |
| INVO Bioscience, Inc. | -8.03 Million USD | -928.886% |
| Telesis Bio, Inc. | -47.72 Million USD | -73.219% |
| Viemed Healthcare, Inc. | 10.24 Million USD | 907.058% |
| Varex Imaging Corporation | -47.7 Million USD | -73.306% |
| Quipt Home Medical Corp. | -2.78 Million USD | -2869.361% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | -632.474% |
| Pulmonx Corporation | -60.84 Million USD | -35.869% |
| Dynatronics Corporation | -2.69 Million USD | -2964.33% |
| Modular Medical, Inc. | -17.47 Million USD | -373.194% |
| ReShape Lifesciences Inc. | -11.38 Million USD | -625.977% |
| Semler Scientific, Inc. | 20.58 Million USD | 501.628% |
| InMode Ltd. | 197.91 Million USD | 141.768% |
| Bruker Corporation | 427.2 Million USD | 119.351% |
| Cytosorbents Corporation | -28.5 Million USD | -189.984% |
| DexCom, Inc. | 541.5 Million USD | 115.266% |
| Align Technology, Inc. | 445.05 Million USD | 118.575% |
| Viveve Medical, Inc. | -22.02 Million USD | -275.298% |
| ZimVie Inc. | -393.28 Million USD | 78.98% |
| Movano Inc. | -29.28 Million USD | -182.304% |
| Cytek Biosciences, Inc. | -12.14 Million USD | -580.499% |
| Nexalin Technology, Inc. | -4.64 Million USD | -1678.279% |
| DIH Holdings US, Inc. Class A Common Stock | 640.19 Thousand USD | 13012.764% |
| Tandem Diabetes Care, Inc. | -222.61 Million USD | 62.865% |
| Profound Medical Corp. | -28.56 Million USD | -189.359% |
| Insulet Corporation | 206.3 Million USD | 140.071% |
| enVVeno Medical Corporation | -23.51 Million USD | -251.535% |
| Surmodics, Inc. | -11.54 Million USD | -616.228% |
| iCAD, Inc. | -4.84 Million USD | -1605.529% |
| Nuwellis, Inc. | -20.2 Million USD | -309.06% |
| Biotricity, Inc. | -14.09 Million USD | -486.529% |
| iRhythm Technologies, Inc. | -123.4 Million USD | 33.012% |
| Aethlon Medical, Inc. | -12.2 Million USD | -577.145% |
| InspireMD, Inc. | -19.91 Million USD | -315.078% |
| PAVmed Inc. | -64.17 Million USD | -28.815% |
| BIOLASE, Inc. | -20.63 Million USD | -300.674% |
| Beyond Air, Inc. | -60.24 Million USD | -37.225% |
| FONAR Corporation | 10.56 Million USD | 882.284% |
| AxoGen, Inc. | -21.71 Million USD | -280.673% |
| Vivani Medical, Inc. | -25.65 Million USD | -222.263% |
| Tactile Systems Technology, Inc. | 28.51 Million USD | 389.907% |
| Inari Medical, Inc. | -1.63 Million USD | -4952.995% |
| UFP Technologies, Inc. | 44.92 Million USD | 284.015% |
| QT Imaging Holdings, Inc. | -5.13 Million USD | -1510.71% |
| Heart Test Laboratories, Inc. | -6.6 Million USD | -1151.543% |
| Tenon Medical, Inc. | -15.58 Million USD | -430.563% |
| Autonomix Medical, Inc. Common Stock | -15.42 Million USD | -435.894% |
| Co-Diagnostics, Inc. | -35.33 Million USD | -133.966% |
| AdaptHealth Corp. | -678.89 Million USD | 87.823% |
| Sintx Technologies, Inc. | -8.25 Million USD | -900.932% |
| NanoVibronix, Inc. | -3.71 Million USD | -2127.621% |
| Quanterix Corporation | -32.33 Million USD | -155.666% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | -632.474% |
| Sensus Healthcare, Inc. | 485 Thousand USD | 17144.742% |
| Pacific Biosciences of California, Inc. | -306.73 Million USD | 73.049% |
| TransMedics Group, Inc. | -25.02 Million USD | -230.298% |
| ReWalk Robotics Ltd. | -22.13 Million USD | -273.501% |
| NeuroMetrix, Inc. | -6.52 Million USD | -1166.057% |
| Hyperfine, Inc. | -44.23 Million USD | -86.869% |
| Establishment Labs Holdings Inc. | -78.5 Million USD | -5.306% |
| Biomerica, Inc. | -5.97 Million USD | -1282.854% |
| Bone Biologics Corporation | -8.94 Million USD | -823.785% |
| AVITA Medical, Inc. | -39.16 Million USD | -111.056% |
| Bluejay Diagnostics, Inc. | -9.95 Million USD | -730.5% |
| Silk Road Medical, Inc | -55.74 Million USD | -48.3% |